First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Advanced Malignant Neoplasm
- Acute Myeloid Leukemia
- Mixed Lineage Leukemia
- Mixed Lineage Acute Leukemia
- Acute Leukemia of Ambiguous Lineage
- Mixed Phenotype Acute Leukemia
- Acute Lymphoblastic Leukemia
Interventions
- DRUG: Ziftomenib
- DRUG: Midazolam
- DRUG: Itraconazole
Sponsor
Kura Oncology, Inc.